Skip to main content
Premium Trial:

Request an Annual Quote

Genetics Institute Licenses Pangea's Informatics Tools

Premium

OAKLAND, Calif.--Genetics Institute, a research unit of Wyeth-Ayerst Laboratories, has licensed Pangea's bioinformatics tools for use in its genomics-based drug discovery efforts. Pangea said its tools for clustering and aligning expressed-sequence tags (ESTs) will allow Genetics Institute to increase "the sensitivity with which molecular targets can be identified and the selectivity with which they can be validated."

Gordon Wong, senior director of research at Genetics Institute, claimed that his company has developed a leading position in genomics-based drug discovery through its proprietary gene isolation and gene expression monitoring technologies. He said, "Reducing the complexity and redundancy inherent in large EST databases will increase the efficiencies of these technologies and their effectiveness in drug discovery."

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.